Axim Biotechnologies, Inc. (OTCQB: AXIM), a leading developer of rapid diagnostic testing for ocular and systemic conditions, today announced that it has filed a Pre-Submission (Pre-Sub Q) with the U.

Favipiravir offers hope against the Chandipura virus. Studies by the National Institute of Virology show promising results. The drug reduces viral load in infected animals. Chandipura outbreaks have ...

Researchers at Delhi Technological University discover potent anti-cancer compounds in Himalayan tuber Dioscorea deltoidea, ...